5DL-13599-18905
3 vaccinations
1 coded response
36 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-15
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Registered in v-safe
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-29
-
2021-05-06
Dose 2 — Pfizer-BioNTech
-
2021-05-06
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-05-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-20
- 2021-05-29
- 2021-06-03
- 2021-06-10
- 2021-06-17
- 2021-08-05
- 2021-11-04
-
2021-11-26
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-11-27
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, NauseaAdult check-in
-
2021-11-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-11-30
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-02-25
- 2022-05-27
-
2022-11-26
Survey response — 12 months, dose 3MedDRA: Drug hypersensitivity, Herpes zoster — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Allergic reaction to medication, shinglesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-26
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-11-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-15 | Pfizer-BioNTech | |
| 2 | 2021-05-06 | Pfizer-BioNTech | |
| 3 | 2021-11-26 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-26 | Unsuccessful |
Free text
Release 12 — 12 months, dose 3
Symptoms: Allergic reaction to medication, shingles
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Drug hypersensitivity | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release